SCHEMBL9742014

SCHEMBL9742014

Cc1ccc(S(=O)(=O)C[N+](=O)[O-])c(C)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.41
POLB P06746 2/20 0.41
MEP1B Q16820 1/20 0.41
RAPGEF4 Q8WZA2 2/20 0.40
ALDH1A1 P00352 5/20 0.40
MAPT P10636 2/20 0.40
HPGD P15428 1/20 0.40
ALOX12 P18054 1/20 0.40
GFER P55789 1/20 0.40
CYP3A4 P08684 2/20 0.39
TSHR P16473 1/20 0.39
KMT2A Q03164 1/20 0.39
LMNA P02545 1/20 0.38
GAA P10253 1/20 0.38
PDE2A O00408 1/20 0.37
PDE5A O76074 1/20 0.37
ALOX15 P16050 1/20 0.37
NFKB1 P19838 1/20 0.37
APEX1 P27695 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9652718 0.79 ALDH1A1 (0.43) SMN1; SMN2RAPGEF4ALDH1A1ALOX12CYP3A4
SCHEMBL3253706 0.77 MEP1B (0.47) SMN1; SMN2POLBMEP1BRAPGEF4ALDH1A1
SCHEMBL10407436 0.77 RAPGEF4 (0.50) SMN1; SMN2POLBMEP1BRAPGEF4ALDH1A1
SCHEMBL9711160 0.77 RAPGEF4 (0.44) AKR1B1SMN1; SMN2RAPGEF4ALDH1A1MAPT
SCHEMBL9711140 0.76 ALDH1A1 (0.55) AKR1B1ALDH1A1MAPTCYP3A4KMT2A
SCHEMBL9740622 0.75 ALDH1A1 (0.40) AKR1B1POLBALDH1A1CYP3A4TSHR
SCHEMBL9711168 0.75 SOD1 (0.49) MAPTTSHRKMT2A
SCHEMBL4398061 0.74 MEP1B (0.45) SMN1; SMN2POLBMEP1BRAPGEF4ALDH1A1
SCHEMBL6916390 0.74 SMN1; SMN2 (0.47) SMN1; SMN2POLBMEP1BRAPGEF4ALDH1A1
SCHEMBL10407448 0.73 RAPGEF4 (0.46) SMN1; SMN2POLBMEP1BRAPGEF4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5153227-A Treatment of diabetes and galactosemia complications IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1992-10-06 US disclosed